GSK R&D Chief Hal Barron Lays Out New R&D Strategy Focused on Genetics and Immune-SystemAllbiopro2018-07-26T01:44:46+09:007월 26th, 2018|
Takeda’s Alunbrig Shows Superiority Over Pfizer’s Xalkori in Some Lung Cancer PatientsAllbiopro2018-07-26T01:44:18+09:007월 26th, 2018|
Pfizer Plans $465 Million Project in Michigan, Part of its $5 Billion Manufacturing PlanAllbiopro2018-07-26T01:43:52+09:007월 26th, 2018|
11 Babies Die After Pregnant Women Given Viagra During Dutch Drug TrialAllbiopro2018-07-26T01:43:24+09:007월 26th, 2018|
China Biopharma Company Risks De-Listing After Data FraudAllbiopro2018-07-26T01:42:58+09:007월 26th, 2018|
Alector Closes $133 Million to Expand Alzheimer’s ProgramsAllbiopro2018-07-26T01:42:32+09:007월 26th, 2018|
Novartis Spinout resTORbio Hits Endpoints on Phase II Trial of Respiratory InfectionsAllbiopro2018-07-26T01:42:06+09:007월 26th, 2018|
Nabriva Acquires Zavante Therapeutics and its Late-Stage AntibioticAllbiopro2018-07-26T01:41:38+09:007월 26th, 2018|
Gottlieb Is Backing Biosimilars In a Big Way. Does It Matter?Allbiopro2018-07-26T01:41:12+09:007월 26th, 2018|
Merck’s Keytruda shores up head and neck case with first-line trial winAllbiopro2018-07-26T01:40:46+09:007월 26th, 2018|
Gilead’s Truvada for PrEP can reduce HIV rates, but activists decry unequal accessAllbiopro2018-07-26T01:40:20+09:007월 26th, 2018|
Novartis study validates need for better migraine treatment, as Novartis-Amgen drug hits marketAllbiopro2018-07-26T01:39:52+09:007월 26th, 2018|
Pall Corporation And BioSciencesCorp Launch Strategic Partnership To Support Industry Drive Towards Integrated End-To-End BioprocessingAllbiopro2018-07-26T01:39:23+09:007월 26th, 2018|
Canadian cannabinoid biotech Inversago looks to the clinicAllbiopro2018-07-26T01:38:54+09:007월 26th, 2018|
resTORbio surges as midstage data set up phase 3 for drug to prevent RTIs in the elderlyAllbiopro2018-07-26T01:38:28+09:007월 26th, 2018|
GlaxoSmithKline’s big R&D idea? Focusing on the immune system, as Barron injects new philosophyAllbiopro2018-07-26T01:38:02+09:007월 26th, 2018|
GlaxoSmithKline makes $300M investment in 23andMe, forms 50-50 R&D pactAllbiopro2018-07-26T01:37:34+09:007월 26th, 2018|
Alector raises $133M in 5th VC round to push neuro-immunology drugs into Alzheimer’s trialsAllbiopro2018-07-26T01:37:00+09:007월 26th, 2018|
